Alterola Biotech, Inc. (ABTI)

USD 0.0

(0.0%)

Market Cap (In USD)

4.37 Million

Revenue (In USD)

-

Net Income (In USD)

-1.54 Million

Avg. Volume

17.77 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.0023-0.022
PE
-
EPS
-
Beta Value
1.455
ISIN
US02152V1035
CUSIP
02152V103
CIK
1442999
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. David John Hitchcock O.B.E.
Employee Count
-
Website
https://alterola-abti.com
Ipo Date
2010-05-05
Details
Alterola Biotech, Inc., a pharmaceutical company, engages in the development of cannabinoid and cannabinoid-like molecules. It focuses on the development of regulated human and animal health pharmaceuticals and regulated food products; production of active pharmaceutical ingredients and food-grade ingredients; and formulation and drug delivery for improved bioavailability, solubility, and stability. The company is based in Birkenhead, the United Kingdom.